Home > Insider Trading > Filing (0002007919-24-000006)

Filing Details

Accession Number:: 0002007919-24-000006
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-06-04 17:27:32
Reporting Period:: 2024-05-31

Accepted Time:: 2024-06-04 17:27:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
2007919	Inhibrx Biosciences Inc.	INBX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1366268	Faiz Jon Kayyem	C/O Inhibrx, Inc. 11025 North Torrey Pines Road, Suite 200 La Jolla CA 92037		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-05-31	70,193	$16.14	876,268	No	4	P	Indirect	By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust
Common Stock	Acquisiton	2024-06-03	46,792	$16.61	923,060	No	4	P	Indirect	By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust
Common Stock	Acquisiton	2024-06-03	80,738	$17.90	1,003,798	No	4	P	Indirect	By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust
Common Stock	Acquisiton	2024-06-04	65,337	$17.44	1,069,135	No	4	P	Indirect	By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust
Common Stock	Acquisiton	2024-06-04	23,726	$18.24	1,092,861	No	4	P	Indirect	By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust
No	4	P	Indirect	By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust
No	4	P	Indirect	By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust
No	4	P	Indirect	By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust
No	4	P	Indirect	By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust

Footnotes

The shares were purchased in multiple transactions at prices ranging from $15.75 to $16.25, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
The shares were purchased in multiple transactions at prices ranging from $16.25 to $16.75, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
The shares were purchased in multiple transactions at prices ranging from $17.40 to $18.10, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
The shares were purchased in multiple transactions at prices ranging from $17.01 to $18.00, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
The shares were purchased in multiple transactions at prices ranging from $18.01 to $18.50, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.